The popular drug price cut will cancel the 7%-15% profit margin on drugs sold, in order to change the situation of public hospitals being "sustained by drug sales for medical services". The new round of pilot medical reform in China will cancel the markup on drugs sold by public hospitals. Meanwhile, patients will have to pay additional pharmaceutical service fees for services such as diagnosis. Yesterday, at this year's national health work conference, Health Minister Chen Zhu elaborated on the new Chinese medical reform policy. Chen Zhu said that this year marks the comprehensive launch and overall promotion of deepening the medical and health system reform.